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Abstract
Sevoflurane: Practice Change Integration
Quality Improvement for Pharmacoeconomic Accountability
Kelly M. Meyers
Background: Pharmacoeconomic accountability is increasingly of concern to patients, institutions, and
healthcare payors alike. Annual sevoflurane expenditure at a large university hospital exceeds $300,000
(personal communication, Eric Likar). Sevoflurane is a liquid, volatile anesthetic delivered from a
vaporizer, through a breathing circuit to a patient. Multiple studies focused on reducing sevoflurane use
note significant cost savings were attained with a variety of techniques. Moreover, using less
sevoflurane reduces the environmental impact of volatile agents which are potent greenhouse gases.
Through simple interventions, such as a brief staff education and reminders, Lethbridge et al. (2007)
demonstrated over a fifty-percent reduction in sevoflurane use. At the beginning of a case and during
the surgical or maintenance phase of anesthesia, vaporized sevoflurane induces and maintains
unconsciousness in the patient.
Objective: The project aims were to increase provider knowledge, attitude, and skills to decrease
expenditures on sevoflurane in an anesthesia department at a large university hospital.
Methods: An educational presentation, highlighting the potential benefits of using reduced fresh gas
flows to deliver sevoflurane, was given to all anesthesia providers at a large university hospital. Lewins’
Change Theory provided the scientific underpinning for the educational intervention about sevoflurane
providing information to motivate anesthesia providers to change their practice. The educational
program was followed by academic detailing throughout the study period to reinforce the goal of
lowering sevoflurane average fresh gas flows. Data collection focused on provider knowledge and
attitude using a pre/post education survey. Before and after survey responses were analyzed using a
paired t-test. Review of a convenience sample of 300 consecutive same-day-surgery pediatric cases,
that used sevoflurane for induction and maintenance of anesthesia, separated into three groups of 100
cases each. These sets-baseline and 1 month and 3 months-were compared for average fresh gas flow,
procedure length, and minutes to airway and analyzed using ANOVA and Tukey’s test.
Results: Provider knowledge and attitude measured using a Likert scale increased across all providers.
Average fresh gas flow use decreased with each consecutive group and reached statistical significance at
month 3, with a decrease in average fresh gas flows of 15%.
Discussion: Excess sevoflurane is carried into a waste gas system where it is exhausted into the
environment. Fresh gases used to deliver sevoflurane are frequently higher than necessary and increase
the production of sevoflurane as a waste anesthesia gas. The opportunity for reducing sevoflurane use
and institutional expenditure on sevoflurane exists while increasing sustainability.
Conclusion: An educational intervention increased anesthesia provider knowledge, attitude, and skill
regarding the use of sevoflurane for the induction and maintenance of anesthesia in a pediatric sameday-surgery population. Reducing sevoflurane use can improve pharmacoeconomic targets and
ultimately reduce the environmental impact of potent greenhouse gases.
Keywords: sevoflurane, fresh gas flows, induction, maintenance, educational intervention,
pharmacoeconomic, sustainability.
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1
Sevoflurane: Practice Change Integration
Quality Improvement for Pharmacoeconomic Accountability
Introduction
Cost conscientiousness is a pressing issue in healthcare in general as US healthcare expenditures
have continued to climb for many years. According to the leadership in the anesthesia department at
the hospital of interest, huge financial losses reaching over forty million dollars have occurred so far
during the coronavirus pandemic. Capital budget purchases in the anesthesia department were
indefinitely on hold as the pandemic unfolded. The support of the chief anesthetist was gained by
detailing the proposed project and potential financial savings. Similarly, support from the operating
room pharmacy director, and the coordinator of internet technology management (IT) for the
anesthesia department were obtained, as well as buy-in from leadership in the department of
anesthesiology. To facilitate evidence-based practice (EBP) change, a comprehensive approach that
involves stakeholders at all levels of planning is essential.
Problem Description
Sevoflurane is a volatile anesthetic agent widely used in the delivery of anesthesia. Lethbridge et
al. (2007) documented its rising popularity in anesthesia. The authors noted a 42% increase in use
worldwide and a 55% increase in the US over a four-year period. The safe, rapid on and offset have
given it preference over previously developed anesthesia gases (Cote et al., 2019). As healthcare costs
have risen, the expense of using sevoflurane has increasingly come under scrutiny. Its use also
contributes to the production of greenhouse gases and contributes to unnecessary workplace exposure
(Kennedy et al., 2019). Sevoflurane, dosed in percentages, is administered through the flow of other
gases. These other gases-oxygen, air, and nitrous oxide flow in liters per minute (LPM) and are referred
to as fresh gas flows (FGF). If these flows are higher than necessary, excess sevoflurane is wasted. Many
anesthesia techniques show how to decrease sevoflurane use, while providing the same safe, effective
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anesthetics (Kennedy et al., 2019; Lethbridge et al., 2007; Ryu et al., 2011; P. Singh et al., 2014).
Although well documented, strategies to decrease sevoflurane waste sometimes fail to reach clinical
practice or are maintained after their initial impact.
Available Knowledge
Sevoflurane is frequently used in pediatric patients prior to intravenous (IV) access. Liquid
sevoflurane is vaporized through a mask and induces unconsciousness, allowing placement of an
intravenous line while the child is unaware. The sevoflurane may be delivered at up to 8% via FGF in
LPM (Cote et al., 2019). This technique avoids any needle sticks while the child is awake. Once IV access
is obtained, the surgery can ensue with analgesia or other anesthetic adjuncts to be delivered via the IV.
The sevoflurane, titrated for effect, maintains the anesthetic depth required after the initial induction,
typically around 2% (Cote et al., 2019).
While inducing a pediatric patient with sevoflurane, fresh gases -oxygen, air, or nitrous oxide
may flow > 12 LPM or more with 8% sevoflurane. This process of induction, IV-line placement, and then
securing of the airway can take some time, particularly if the child has difficult IV or airway access (Cote
et al, 2019). It is during induction and the maintenance phase of anesthesia that FGF can be turned
down, delivering the same concentration of sevoflurane while reducing the volume used (Tyagi et al.,
2014; Gupta & Datta, 2020). For example, inducing a patient with 8% sevoflurane at FGF of 12 L then 4
LPM for maintenance versus inducing with 6 L and maintaining with 1 LPM. Using lower FGF during
induction and maintenance anesthesia phases utilizes less sevoflurane and is the more cost-conscious
choice (Kennedy et al.; 2019; P. Singh et al., 2014).
Literature Review & Synthesis
Three databases PubMed, CINAHL, and Cochrane, were searched for relevant studies aimed at
determining decreasing sevoflurane usage through modification of use. Seven relevant articles were
found using the key words: “sevoflurane,” “cost”, and “induction”. Articles were in English and
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published within the last ten years, except one. This article specifically addressed sevoflurane usage in a
children’s hospital after an educational intervention intended to decrease sevoflurane usage (Lethbridge
et al., 2007). Literature review is summarized in Table 1.
Four randomized controlled trials (RCTs) compared various sevoflurane administration
techniques to determine which methods reduced sevoflurane use and associated costs (Gupta & Datta,
2020; A. Singh et al., 2019; P. Singh et al., 2014; Tyagi et al., 2014). Three other articles looked at
sevoflurane consumption before and after an intervention. Two of those were educational interventions
encouraging conscientious use of sevoflurane (Kennedy et al., 2019; Lethbridge et al., 2007). The other
study compared sevoflurane usage before and after a policy change (Ryu, et al., 2011). The studies using
an intervention to decrease sevoflurane usage assessed the use over different time frames. Lethbridge
et al. (2007) collected data on sevoflurane usage over a two week period prior to intervetion, then
calculated the sevoflurane usage for the two week period post intervention. Ryu et al. (2011) calculated
sevoflurane usage for five weeks prior to and fifteen weeks after their intervention. Kennedy et al.
(2019) evaluated sevoflurane usage for three months prior to intervention, then calculated the usage in
the 6 months post intervention.
Evaluation of sevoflurane adminstration using higher versus lower FGF’s can occur when
comparing different techniques (Ryu et al., 2011) or by comparing the before and after effects of an
intervention aimed at decreasing sevoflurane usage (Tyagi et al., 2014). First, Ryu et al. (2011)
investigated the effect of implementing a policy reducing maintenance flows to 1 LPM with anesthesia
machines defaulting to 6 LPM when turned on for induction. Staff were informed of the changes and
provided reinforcement throughout the study. Tyagi et al. (2014) compared three methods of
anesthesia: propofol induction, sevoflurane 8% with 6 LPM FGF until desired dose reached in the
patient, then 1 LPM for the rest of the case, propofol induction with sevo as in first method but with 0.5
LPM FGF for anesthesia maintenance, and sevoflurane induction at 6 LPM then 0.5 LPM of FGF for
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maintenance of anesthesia. Their studies confirmed existing data that shows administering sevoflurane
using lower FGF for anesthesia maintenance is more cost effective. They did not, however, look
specifically at induction and its influence on sevoflurane consumption (Ryu et al., 2011; Tyagi et al.,
2014).
Three studies considered sevoflurane usage during induction and found using lower flows for
sevoflurane induction in children resulted in decreased sevoflurane consumption while providing
equivalent safe and efficient induction conditions (Gupta & Datta, 2020; A. Singh, et al., 2019; P. Singh,
et al., 2014). Lethbridge et al., (2007) looked at the effect of an intervention on decreasing overall
sevoflurane use in a pediatric hopsital where many of the cases were performed using a sevoflurane
inhalational induction. They evaluated the impact of lower FGF during inhalational inductions and
maintenance of anesthesia on overall sevoflurane use. Reductions in sevoflurane consumption were
found resulting in significant cost savings. Similarly, Kennedy et al., (2019) reviewed cases using
sevoflurane for induction and maintenance. The data reinforced that FGF rates correlate with
sevoflurane consumption and that modifying rates at induction significantly reduces average FGF rates.
A variety of methods were used to quantitate sevoflurane usage. These included weighing
sevoflurane vaporizers (Tyagi et al., 2014), using anesthesia machine calculations (Gupta & Datta, 2020),
formulaic calculations (Singh et al., 2014), and averaging FGF rates during a case (Kennedy et al., 2019) .
The evaluation of FGF rates for averaging and comparison for study is a pragmatic approach to evaulate
sevoflurane usage. Additionally, using electronic data extraction, multiple data sets can be obtained for
analysis while maintaining de-identification of individual patients.
All of these studies revealed a decrease in sevoflurane use whether they were looking at
comparing techniques or looking at the impact of an intervention. The studies showing an anesthesia
technique that lowered sevoflurane usage, focused on decreasing FGF rates. The decrease in FGF rates
was during induction or during induction and the anesthesia maintenance phase. Tyagi et al. (2014)
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compared sevoflurane-only anesthetics using two different FGF rates and a sevoflurane plus propofol
anesthetic. They found the lower flow, sevoflurane-only technique to be the most cost effective.
Comparing different anesthesia induction techniques, P. Singh et al. (2014) found the lower-flow
technique used less sevoflurane and was more cost effective.
Three of the four studies comparing anesthesia techniques to reduce sevoflurane usage focused
on pediatric surgical patients (Gupta & Datta, 2020; A. Singh et al., 2019; P. Singh etal., 2014). Pediatric
patients are frequently anesthetized using inhalation techniques with higher FGF to get the patient to
sleep quickly. This provides an opportunity to focus on reducing usage, because sevoflurane is used for
both induction and maintenance of anesthesia. In adults or children with an IV line, induction of
anesthesia doesn’t involve inhalation of sevoflurane, as IV medications are used to induce
unconsciousness (Cote et al., 2019). Of the intervention studies, one (Lethbridge et al., 2007) provides
data from a children’s hospital where they looked at the FGF rates before and after educational
reminders to staff. Two other groups studied sevoflurane consumption in four operating rooms over an
eleven month period (Kennedy et al., 2019) or total departmental use of sevoflurane over a twenty
week period (Ryu et al., 2011).
Lowered sevoflurane usage and cost savings were demonstrated by each study that provided
either an educational intervention or reminder (Kennedy et al., 2019; Lethbridge et al., 2007) or a policy
change (Ryu et al., 2011) resulting in a modifcation of technique. The majority of studies comparing
techniques focus on pediatric cases, again, revealing the induction phase as a point of potential cost
savings (Gupta & Datta, 2020; A. Singh et al, 2019; P. Singh et al., 2014). Attainment of the cost savings
was possible using an intervention with staff such as an educational reminder (Kennedy et al., 2019;
Lethbridge et al., 2007) or a policy change (Ryu et al., 2011).
Lethbridge et al. (2007) only studied the effect of their intervention for two weeks, not verifying
the lasting impact of the intervention. In 2014, P. Singh et al. compared a high dose sevoflurane
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induction to an incremental one. A high dose technique is frequently reserved for an uncooperative or
unmedicated child and may not be considered equivalent to an incremental dosing method. In the
studies examining sevoflurane consumption, a theme ‘the need for reinforcement to maintain practice
changes’ emerged (Gupta & Datta, 2020; Kennedy et al., 2019; Lethbridge et al., 2007; Ryu et al., 2011;
A. Singh et al., 2019; P. Singh et al., 2014; Tyagi et al., 2014). Studies also varied in their length of follow
up. Kennedy et al. (2019) discussed the ‘rebound’ of FGF rates six months after the intervention and
suggested regular feedback may be needed to maintain the changes. Without reinforcement, Lethbridge
et al. (2007) noted that routines of using FGF higher than needed tended to return to near baseline at
five months after their intervention. Ryu et al. (2011) implemented a policy change to force use of low
FGF, but less than 50% of staff adopted the change. Sustainment was found to diminish over the 15
week evaluation period.
Unless stakeholders are educated and engaged, adoption of EBP is unlikely. Additionally,
practice change reinforcement is essential. Regardless of what method is employed to decrease
sevoflurane use, validating sustainability is crucial in order to bring about lasting EBP change.
Rationale
Evidence exists showing that sevoflurane waste can be reduced if anesthesia staff are educated
about using lower FGF to deliver the sevoflurane. Unfortunately, evidence does not always translate into
practice. There are several reasons anesthesia providers don’t always adjust FGF rates that might reduce
the waste of sevoflurane. Inexperience may make a provider forget to turn flows down after the
induction phase, or complacency may make a provider less likely to take financial concerns into
consideration (Lethbridge et al., 2007). Other reasons clinicians may fail to integrate known evidence
into practice include large amounts of research with conflicting results, lack of knowledge or negative
attitudes towards EBP, and lack of organizational support for clinicians wishing to implement EBP
(Warren et al, 2016).
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Since many pediatric patients are given anesthesia via mask induction, and anesthesia is
maintained with sevoflurane, opportunity exists to assess, and decrease the use of sevoflurane. An
educational intervention for anesthesia providers which produces a minor practice change, could result
in more efficient use of sevoflurane. The reduction in sevoflurane use could then translate to a decrease
in cost. Providing a pharmacoeconomically responsible anesthetic is supported through evidence, but
many providers induce and maintain sevoflurane anesthesia with higher than necessary flow rates
(Gupta & Datta, 2020). Cost savings can be realized, and there are also potential benefits for patients.
Cote et al. (2019) notes hypothermia in children receiving anesthesia can be a common issue
and higher FGF than necessary for a longer time than necessary can contribute to hypothermia in
smaller patients as room temperature air is flowing around the patient’s core. Fresh gases are
completely dehumidified and can contribute to airway irritation during a time when patients are prone
to laryngospasm and bronchospasm, particularly if they are flowing at rates which are higher than
needed (Cote et al., 2019). Additionally, high FGF also increase anesthesia provider’s sevoflurane
exposure when there is any compromise in a mask seal or disconnect of the breathing circuit. Finally,
sevoflurane, like many other volatile anesthetics, is a strong contributor to greenhouse gases. MacNiell
(2017) noted that in the provision of healthcare services at three major hospitals, anesthesia gases were
found to be the largest contributor to greenhouse gas emissions.
PICO Question
In same day pediatric surgical patients receiving mask inductions, will the implementation of an
EBP educational program on sevoflurane usage for anesthesia providers, compared to usual routine,
decrease the amount of sevoflurane utilized after the program at one and three months?
Theoretical Framework
Lewins’ Change Theory was applied to this project. As described by Petiprin (2016), Lewins’
Change Theory purports behaviors change when there is an imbalance of reasons driving a person to
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change a behavior. If forces of change are equivalent to forces that prevent change, an equilibrium is
present. If forces that drive change are increased, then a change in behavior can occur. In this case, the
educational intervention about sevoflurane would provide information to motivate anesthesia providers
to change their practice.
Lewins’ Change Theory has three phases: unfreezing, change, and refreezing (Petiprin, 2016).
The unfreezing would occur with the presentation of the educational intervention on decreasing
sevoflurane use. The change would occur when the novel information is transformed into the modest
adjustment of using lower flows during sevoflurane administration. Finally, refreezing would occur when
the use of lower sevoflurane flows becomes integrated into practice.
Project Aims
The aims of this project were to implement an educational program of EBP sevoflurane
administration and to evaluate the program impact on sevoflurane use. Additionally, provider attitudes
and knowledge regarding sevoflurane administration were assessed. (See Table 2).
Methods
Needs Assessment
While evidence shows that wasting of anesthesia gases occurs (Lethbridge et al., 2017) and can
contribute significantly to the production of greenhouse gases (MacNiell et al., 2017), that evidence has
not translated into practice at a large university hospital where the author is employed. According to the
operating room pharmacy records, the institution where the project took place has annual expenditures
of approximately $300,000 annually on sevoflurane (E. Likar, personal communication, July 2020). This
project evaluated the impact of an educational intervention with anesthesia staff to produce a decrease
in sevoflurane consumption and associated costs. The setting is affiliated with a Research 1 Doctoral
Extensive Carnegie rated university in the US mid-Atlantic region.
Intervention, Context, & Population
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This project involved the collection of deidentified data from the electronic health records (EHR)
of three groups of 100 cases (N=300 cases total) of pediatric patients undergoing anesthesia for sameday surgery. One group was before and two groups after the educational intervention concerning
evidence-based sevoflurane use for anesthesia providers. Data set one, or baseline was obtained from a
month prior to delivery of the educational intervention and before the start of gathering buy-in from
anesthesia department members. The first post education data set was collected the month
immediately after the educational offering and then again at three months to validate sustainment of
the EBP change. The data collected is the average FGF during an anesthesia case from the time of
anesthesia start to the completion of the surgical procedure. It included pediatric same-day surgery
cases using sevoflurane for mask, also referred to as inhalational induction, and maintenance of
anesthesia. Each month of collection of average FGFs used was determined for 100 cases until a total of
300 cases was reached. The number needed to evaluate was established using Joint Commission
guidelines for quality improvement (QI) projects, input from committee member statistics expert, and
based off numbers utilized in previous interventions.
The intervention was an educational presentation on EBP change, to all anesthesia faculty, staff,
and students, provided as part of a routine anesthesia department grand rounds. The presentation
occurred in a large auditorium with available technology for the presentation of a power point with
accompanying lecture. Adjustments in the delivery of the presentation due to the pandemic required its
presentation virtually via a Zoom link for anesthesia grand rounds for recipients who chose not to attend
a large gathering. A retrospective or pre- post-survey was provided for participants to take after the
presentation via a link to Qualtrics and the data analyzed to determine the immediate impact of the
educational session. The survey compared before and after knowledge regarding sevoflurane and
changes in FGF, as well as attitude toward EBP practice change regarding both economic and
environmental concerns. It was expected that the presentation would be adopted as part of ongoing

10
departmental educational needs. Avorn, (2017) discussed the development of academic detailing – a
concept similar to pharmacy representatives who would come to clinic periodically to provide inservices about new medications on the market and noted two visits in six months was frequent enough
to make an impact on provider’s clinical practice and decision making. Academic detailing is like the
educational strategies used to alter pharmaceutical prescribing practices, including short, intense, one
on one sessions with a content expert or opinion leader (Avorn, 2017). Providing bi-annual education
about EBP sevoflurane use combined with academic detailing during clinical work provided a foundation
for the change (Avorn, 2017). It was provided bi-annually to reinforce the expected practice change and
would then be adopted for onboarding of new anesthesia providers and learners. The presentation
along with academic detailing would reinforce and sustain the EBP practice change. Biannually cost data
would be evaluated with pharmacy and incorporated as part of departmental meetings to reinforce the
economic benefits of the change.
The mission of the healthcare corporation is “to improve the health of the citizens of the
surrounding area served by the hospital through excellence in patient care, research, and education”
(West Virginia University; WVU Medicine, 2020). The project aims encompass delivering safe, costeffective care, while completing EBP implementation and evaluation, which aligns well with the
institution’s mission.
By nature, the delivery of anesthesia involves delivery of a variety of pharmaceutical agents,
sevoflurane being among them. Pharmacy departments frequently have initiatives to decrease drug
costs associated with anesthesia delivery. These initiatives are typically associated with intravenous
drugs that go unutilized, requiring their waste. These unused or unattended medications are visible to
staff working in the operating room, reported to pharmacy, noticed by administrators, and even noted
in inspections by accrediting bodies such as Joint Commission on Accreditation of Healthcare
Organizations. Consequently, there is increased interest in pharmacoeconomic accountability and

11
sustainability within many anesthesia departments. According to the operating room pharmacist at the
project hospital, annual expenditures for sevoflurane are over $300,000. An initiative to decrease these
costs is in line with the efforts of both the anesthesia and pharmacy departments.
In addition to cost benefits, decreasing sevoflurane use has potential benefits for the
environment. MacNeill et al. (2017) studied three hospital systems and found that operating rooms are
significant contributors to environmental pollution. Anesthesia personnel delivering sevoflurane to
patients also face some exposure to sevoflurane during mask induction of anesthesia and during any
disconnects of the breathing circuit during a case. Evaluating greenhouse gas emissions from anesthetic
agents, Sherman et al. (2012) recommended all volatile agents be delivered with the lowest FGF possible
to reduce their impact on the environment. Lowering the amount of FGF, such as oxygen and air
combinations, which carry the sevoflurane, would lessen these exposures and the potential
environmental impacts.
SWOT Analysis
A SWOT analysis determines the strengths, weaknesses, opportunities, and threats to a clinical
project (Bonnel & Smith, 2018). Strengths identified for this project include rapport with current
anesthesia department members, buy-in from pharmacy, and anesthesiology leadership. Additionally,
there were no expected interruptions to workflow with project implementation. The author was the
clinical coordinator of anesthesia as well as a pediatric cardiac anesthesia team member at the
institution of interest, and able to carry out this project as part of QI duties. Cost absorption occurred as
the project was conducted in the author’s clinical role as anesthesia department “release time”. The
economic environment was ideal for a cost savings initiative. An established connection existed with IT
department’s anesthesia specialists. Finally, there is a general cultural interest in environmental impact
and carbon footprint of industries including healthcare. To avoid a conflict of interest, faculty from
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outside of anesthesia were part of the team to ensure objectivity and congruence with the academic
mission of the organization.
Weaknesses included the inability to reach all staff with the educational intervention or
complacency of staff in making changes. As an academic center, an increased number of learners could
have also been a weakness (Kennedy et al., 2019). When developing and advancing airway management
skills, learners often use increased flows to compensate for a poor mask seal. If the mask isn’t snuggly
fitted to the patient’s face, gases can leak out increasing FGF to compensates for the leak. Turnover of
staff or new learners could have also impacted project success as they may not have received or be
aware of the information provided in the educational intervention. Adding the educational intervention
to the onboarding process helped to minimize the potential for missed opportunity to educate staff on
efforts to reduce production of excess waste anesthesia gases.
Opportunities included development of team cohesiveness for a future pediatric anesthesia
team, increased pharmacoeconomic accountability and cost savings, development of interprofessional
relationships through collaboration on the project, and lessening the production of greenhouse gases
and staff environmental exposure to sevoflurane. Low motivation in overworked staff, the lack of
administrative support, and failure to identify cost savings were potential threats. Therefore, the
educational program was incorporated with routine grand rounds (see Appendix A) and documented
administrative support was gained upfront (see Appendix C).
Lastly, pharmacoeconomic accountability is increasingly of concern to patients, institutions, and
healthcare payors. This project aimed to decrease expenditure on sevoflurane at a university hospital.
According to their pharmacy director, expenditures are over $300,000 annually on sevoflurane (E. Likar,
personal communication, July 2020). By decreasing the amount of sevoflurane delivered to patients
undergoing surgery at this hospital, significant cost savings could be realized.
Project Design, SMART Workplan, and Financial Considerations
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Attainment of project aims was through educating staff in a routine meeting on the delivery of
sevoflurane. An EBP educational session was developed by the author (see Appendix A). Approval from
both the university, which deemed the project as non-human subject research (NHSR), and hospital
institutional review boards (IRBs) was obtained in late 2020 (see Appendix D). The EBP intervention was
utilized as a review or update for anesthesia providers’ knowledge base, allowing them to integrate
evidence into their practice that decreases usage of sevoflurane and lowers costs. The educational
intervention was presented during a routine meeting by the investigator. Staff not available to attend
were briefed and surveyed individually as part of the normal workflow routine by the author. Staff not
attending grand rounds the day of the educational intervention were emailed a recorded copy of the
presentation with a link and QR code for the post-education survey. Academic detailing ensued during
clinical activity. On a regular and recurring basis, the investigator checked in with anesthesia staff
concerning the project to assess for any questions or concerns and reinforce the project aims. Two
weeks after the session, a supportive article was provided via the anesthesiology department’s intranet
website with a bi-monthly educational article, which went out to anesthesia staff. The author used the
article as a form of academic detailing to enhance staff understanding, reinforce knowledge, and
willingness to reduce sevoflurane use.
Specifically, this project focused on pediatric, same-day surgery cases at a university hospital.
The data collected was from cases in which pediatric patients received sevoflurane for induction and
maintenance of anesthesia. Because high gas flows deliver high concentrations of sevoflurane, these
types of cases were particularly suited to reducing sevoflurane use. The educational session, however,
was delivered to all anesthesia providers, leaving opportunity for future evaluation of overall
institutional impact and departmental pharmacoeconomic accountability as well as sustainability.
Changes in sevoflurane use were tracked by collecting average FGF rate per case for a total of
300 cases. Included cases were cases in which sevoflurane was used for induction and maintenance of
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anesthesia. Sevoflurane use can be directly correlated with average FGF rates (Kennedy et al., 2019).
The investigator tracked the number of cases to be included in the practice change using an electronic
code list, which was kept on a HIPAA compliant computer, and locked in the investigator’s office.
Average FGF (in LPM) was monitored on 300 total cases. 100 cases in a one-month period before the
educational session, and 100 cases at one month and three months after the educational intervention.
The average FGF rates for the cases was obtained through the electronic health record anonymously in
an excel spreadsheet to track the sevoflurane use over time for comparison and was correlated with the
demographic case data. Once the data was obtained regarding sevoflurane use, the electronic case code
list was destroyed by the investigator using HIPAA compliant electronic methods at the institution.
Reduction of sevoflurane use through similar interventions revealed decreases in sevoflurane use from
26-53% (Lethbridge et al., 2007; Tyagi et al., 2014). As such, a goal was set at a 20% reduction in
sevoflurane use in study cases after the educational session.
There are gaps in the integration of evidence into practice when it comes to using sevoflurane.
Although multiple authors have shown decreases in sevoflurane use with attention paid to technique or
methods using lower flows, it is not an established standard (Kennedy et al., 2019; Lethbridge et al.,
2007). Additional issues in the project may have included bias with the questionnaire for staff, as the
questionnaire was a pre/post questionnaire given one time after the educational presentation.
Anesthesia providers took the post education survey voluntarily, and bias could be present if those who
chose to respond were more motivated to integrate the information into practice or to show a positive
response to the educational information. This type of survey was selected due to it was deemed more
compatible and acceptable with time constraints of providers. Additionally, given the ongoing pandemic,
concern for “mission fatigue” could also have influenced the project. At the projected time of
implementation of this project, staff were a year into a pandemic which significantly altered their
professional schedules and duties as well as their ability to travel and socialize. Staff feelings of burnout
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and frustration could have possibly disincentivized them to participate or to participate fully in the
efforts of this project.
Potential weaknesses may exist in the project design. One of these may be looking at only the
pediatric same-day surgery cases, as they may not be representative of equivalently attainable costsavings in other patient populations. Another may be utilizing average FGF rates for estimating
sevoflurane use. Other less feasible and more technically difficult methods exist. For example, weighing
sevoflurane vaporizers before and after each case or using formulaic calculations (Gupta & Datta, 2020;
Tyagi et al., 2014). These methods may be considered more accurate but are not always utilized because
they can disrupt workflows and be logistically difficult. The impact of the educational intervention could
reach other patient populations, and this data was not captured as part of the project. However, the
study took place at an institution where a new children’s hospital is set to open. There are growing
numbers of pediatric cases occurring which increases the potential impact of focusing on pediatric
patients.
The implementation of this project occurred as part of a QI effort in the anesthesia department
under leadership of the investigator. A timeline was created for the project and then adjusted over time
as delays occurred in proposal editing, approval, and in obtaining an available date and time for
presentation at anesthesia grand rounds (see Figures 1 and 2). The project was approved by
anesthesiology leadership from department chairs of anesthesiology and pediatric anesthesiology and
the residency coordinator (see Appendix C). The investigator had dedicated time as part of
administrative duties associated of the position, requiring no supplemental salaried staff. Additionally,
project work occurred during off-work (unpaid) hours with approval of the department chief. Delivery of
the educational intervention for anesthesia staff occurred as part of a routine meeting, requiring no
additional staff hours. Gathering of electronic data to quantitate sevoflurane use was through
coordination with IT and pharmacy colleagues demonstrating the investigator’s team leadership and
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collaboration skills. Incidental costs of printing or other nominal incidentals incurred were absorbed by
the investigator. Project hours were tracked in order to determine investigator time to implement the
practice change.
This QI project aimed to increase pharmacoeconomic accountability in the anesthesia
department at a large university hospital in WV by decreasing the amount of sevoflurane wasted.
Outcomes
Evaluation of outcomes is an important part of any QI project. Evaluation of outcomes can
demonstrate accountability and success or failure of a project (Bonnel & Smith, 2018). Basic
demographic included type of provider (CRNA, MD, SRNA) and length of practice of the anesthesia
providers. This data was collected and reported in aggregate using descriptive statistics. One outcome
measured included the impact of the educational intervention on anesthesia providers’ knowledge of
sevoflurane use and attitudes toward making a minor practice change to decrease use. The other
outcome measured was the use of sevoflurane estimated through anonymous collection of average FGF
rates in pediatric inhalational mask induction cases using sevoflurane (see Appendix E, Evaluation Plan).
Analysis
The impact of the educational intervention was measured in a brief survey provided after the
educational session was given. The post survey data was compared with pre-session responses. The
questionnaire was a retrospective or pre- then post-survey given once after the session. This type of
survey offers strength to the evaluation of impact of the educational intervention by comparing
participants’ knowledge and attitudes before and after the education in a single survey (Taylor-Powell &
Renner, 2009). The questions included inquiry of participants knowledge of sevoflurane use, its impact
on the environment, concerns regarding use of low FGF to deliver sevoflurane, the potential to decrease
sevoflurane use by using lower FGF rates, decrease in costs associated with lower FGF, and willingness
to integrate this knowledge into a minor practice change. The educational intervention was planned and
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delivered in the Spring of 2021. Scores obtained for before-and-after answers on the survey were
compared using a paired t-test. The survey (see Appendix A) was loaded into Qualtrics for ease of
completion and data collection and analysis. It was then piloted in September 2020 with three
anesthesia providers to assess face value and ease of use. The pilot use confirmed congruence with
intent.
Further evaluation of the impact of the educational intervention was generated by tracking
sevoflurane use on a total of 300 designated pediatric cases, 100 cases at baseline and one and three
months each post educational program. If the providers understood and integrated the information
from the educational intervention into their practice, then they would be using lower average FGF rates
to deliver the same dose of sevoflurane. The use of sevoflurane can be measured by monitoring FGF
rates (Kennedy et al., 2019). Fresh gases consisting of air, oxygen, and nitrous oxide are used to deliver
sevoflurane in concentrations up to 8%. It is delivered through a mask in many pediatric cases where an
IV line is not placed until the patient is unconscious from the inhalation of anesthesia gases. The fresh
gases are turned on in combinations chosen by the anesthesia provider to deliver sevoflurane to a
patient. Sevoflurane usage has a linear relationship to FGF rates (Kennedy et al., 2019). The sevoflurane
usage was estimated by tabulating average FGF rates in LPM used during these pediatric cases. The
fresh gas flow rate is recorded in the electronic health record and was obtained anonymously for data
analysis. The FGF rate was averaged from the time the sevoflurane is turned on until the “procedure
finish” event when sevoflurane is turned off. A total of 300 cases had FGF data averaged. Data was
obtained from the EHR using an excel spread sheet developed by the author (see Appendix B). Some
initial manual calculation was required to add minutes of nitrous oxide use into the calculated average
fresh gas flow rate as the EHR reports pulled for each case would not add in any minutes of nitrous oxide
use when calculating average fresh gas flows. The three different sets of average FGF data were
compared using an analysis of variance or ANOVA test. Assistance in statistical analysis was established
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from a statistics expert of the associated university, as part of the project committee. Analysis of the
three data sets determined if there was a significant reduction in average FGF rates. Data extraction and
analysis occurred in the spring of 2021 through the early fall of 2021 until 100 cases of data were
obtained for each data set time point (baseline, month 1, and month 3).
Ethical Considerations
Approval from both the university IRB and hospital nursing research council was obtained (see
Appendix D). Data was obtained from EHRs in collaboration with the anesthesia IT department and
pulled through reports created by IT and run by the investigator. All information was deidentified and
stored on a password protected computer or encrypted flash drive. No human subjects were
manipulated in this project. Delivery of the educational presentation to staff was part of the routine
departmental educational processes and did not involve coercion or manipulation of staff. The pre/postpresentation survey was anonymous and voluntary in nature. Taking of the survey was neither
incentivized nor punitive in nature. Additionally, a project team member that was not part of the
anesthesia department (Faculty of Record) helped in maintaining project objectivity and addressing any
potential conflicts of interest from the author or subject matter expert, who are both members of the
anesthesia department used to demonstrate this QI project to staff or learners. Employing an EBP
educational presentation to induce a lasting practice change was one of the aims of this project and is
congruent with the mission and vision of the institution.
Results
Aim 1
Aim 1 for this project was implementation of an EBP educational program to decrease
sevoflurane use. This was carried out in Spring 2021 through objectives of delivering the lecture
discussion at an anesthesia grand rounds. No problems were encountered in the delivery of the
education or with the academic detailing that ensued. After delivery of the educational presentation on
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sevoflurane administration, the pre-post survey on knowledge and attitudes towards sevoflurane use
was offered via a link was delivered to all attendees for completion (objective 1b). Anesthesia staff who
were not present were provided the educational presentation in person or via email with recorded
audio. Participants completed the survey via link or QR code taking them to the Qualtrics survey.
Participants who were not present at the initial presentation were delivered the educational material
over the next three working days excluding some per diem staff or staff members on vacation.
Comprehensive academic detailing ensued with anesthesia providers throughout the department during
individual breaks in operating rooms or during staff break times in the anesthesia break room in the
months following the educational presentation on a minimum of a weekly basis. Staff numbers included
a total of sixty-seven full or part time CRNA’s, thirty-five attending anesthesiologists, and twenty-four
residents were offered the education and survey (n=126). On a given day there are varying numbers of
student nurse anesthetists from different programs, typically between two and four. Of those, seventythree anesthesia providers took the Qualtrics survey with sixty-six (52%) participants completing the
survey.
Survey respondents were largely Certified Registered Nurse Anesthetists (65.3%), followed by
anesthesiology residents (13.9%), anesthesiologists (12.5%), and student nurse anesthetists (8.3%).
Nearly half of respondents (45.8%) had 0-5 years of experience. Only 22.2% of those respondents were
either anesthesiology residents or student nurse anesthetists. The remainder were CRNA’s or residents
in their first few years of practice. Of respondents, 13.9% had six to ten years of experience. About onefifth (22.2%) had greater than fifteen years of experience and 18.1% had eleven to fifteen years of
experience. As expected, student nurse anesthetists and residents tended to have less years of
experience. Summary of provider demographic data are detailed in Table 3, Survey Demographic Data:
Provider Type & Years of Practice.
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Survey questions regarding knowledge and attitudes towards sevoflurane use, FGF rates, costs,
and environmental pollution were recorded through Qualtrics (https://www.qualtrics.com). The data
was then input into SPSS software for statistical analysis. Using a Likert scale for before and after ratings
of presentation, “1” indicated “none” and “5” indicated “a lot.” A paired t-test was used to compare
before and after scores to each question. Through survey answers, respondents noted a statistically
significant change in knowledge regarding sevoflurane waste contributing to environmental pollution
and increasing costs. In addition, respondents’ attitudes regarding willingness to integrate evidence into
practice, change their practice to reduce sevoflurane waste to reduce environmental pollution, and
change practice to reduce costs also increased significantly (p<0.001) for all questions regarding
knowledge and attitudes. Statistical analysis including means, standard deviation and significance are
detailed in Table 4. In response to “my knowledge of sevoflurane’s contribution to environmental
pollution,” respondents mean score before was 2.74, and after was 4.48. In response to “my knowledge
of how much fresh gas flows impact sevoflurane waste” respondents mean score before was 2.12 and
after was 4.52. In response to “my willingness to integrate evidence into practice,” respondents mean
scores before and after were 3.60 and 4.67 respectively. In response to “my willingness to change my
practice to reduce sevoflurane waste and environmental pollution,” respondents’ means scores were
3.31 before and 4.69 after. In response to “my willingness to change my practice when using sevoflurane
to reduce healthcare costs,” respondents’ mean score before was 3.35 and 4.56 after receiving
education. Both before and after responses for each knowledge or attitude question from the survey are
detailed in Figures 3-7.
Aim 2
Aim 2 was to evaluate the impact of an educational Program on EBP sevoflurane use on
sevoflurane usage. Deidentified baseline data from 100 cases meeting inclusion criteria was collected at
three different time intervals (N=300) for evaluation of average fresh gas flows, time to airway, and
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procedure length for baseline (data set 1), month 1 (data set 2), and month 3 (data set 3). The collection
of these data sets addressed objectives 2a, 2b, and 2c (see Appendix E). Case inclusion criteria were
pediatric, same-day-surgery cases, using sevoflurane for induction and maintenance of anesthesia, and
with a procedure length of less than 180 minutes. Due to impacts on case load at the hospital from the
COVID-19 pandemic, baseline data the month prior to the delivery of the educational material was
lower than usual and baseline data was retrieved from the fall prior to the pandemic. Obtaining data
from this period excluded holiday fluctuations as well as impacts of the pandemic on case numbers as
well as any early influences of discussion of project development influencing providers in the
department to begin making practice changes. One month after the educational presentation was
delivered to staff, data for another 100 cases was collected. This process was repeated at three months
after the educational presentation. Once data collection was underway for month three, it was noted
that data for same-day-surgery pediatric cases was being collected from only the main operating room
where both same-day-surgeries and inpatients or post-operative admission cases occur and not the
same-day surgery suite located on a separate floor of the institution. This resulted in a disproportionate
representation of residents in the data as compared to the actual ratio of residents and Certified
Registered Nurse Anesthetists at the institution. Upon review with committee members, it was decided
to proceed with the data obtained, as the aim of the project was to determine if, as a department an
impact can be made on waste of sevoflurane and not to compare the results of based upon provider
type. All months of data collection required going into the first week of the following month to obtain
the final cases to reach 100 for each data set. Cases were excluded if they did not meet the criteria
previously listed. Others were excluded if data was missing from the record due to the electronic record
not being started in a timely fashion or data interface down times or glitches created gaps in data
collection in the EHR’s anesthesia record making accurate recording of average FGF impossible.
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Parametric testing was used to compare the means between groups: baseline, month 1, and
month 3. Specifically, ANOVA was conducted on the three data sets to determine if the difference
between means was significant between groups in comparison of procedure length in minutes, time to
airway in minutes, and average fresh gas flow in liters per minute (L/min). See Table 5 for the ANOVA
summary. Average procedure length was the total number of minutes it took to complete the procedure
noted in the EHR from the event “incision” until the event “procedure stop.” Overall average procedure
length (M=59, N=300) minutes. See Figure 10 for a graphic representation of procedure length. The
ANOVA of procedure length showed procedure length was not statistically significant between groups,
(F=.878, p=.417). Mean procedure lengths were in minutes 56 (data set 1=baseline), 58 (data set
2=month 1), and 63 (data set 3=month 3) respectively. See Table 2 for descriptive statistics of procedure
length, time to airway, and average FGF.
The overall mean number of minutes to secure the airway was 7.4 minutes (N=300). The ANOVA
of minutes to airway showed means were not statistically different, (F=1.836, p=.161). Minutes to
secure airway were noted from the minute the event “induction” was noted in the EHR until the event
“intubation” or “LMA placement” was noted. In the case of a mask only case where the airway was not
secured with a device, event of “anesthesia release” was noted for airway securement. Mean minutes to
secure airway also did not differ significantly between data sets and were 8.1, 7.3, and 6.9 minutes
respectively for each data set (baseline, 1 month and 3 months). See Figure 8 for a graphic of time to
airway for each data set and Table 5 for the ANOVA summary.
Overall mean FGF was 3.88 L/min, (M=3.88, N=300). Mean FGF decreased from baseline to
month one, and from month 1 to month 3 (see Figure 9). Fresh gas flows were averaged from the start
of sevoflurane on the anesthesia record until event “procedure finish” when anesthetic gas
administration ceased. A one-way ANOVA was conducted to evaluate the relationship between delivery
of an educational intervention on EBP sevoflurane use and FGF before the education and after at 1 and
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3 months. The independent variable included impact of education, baseline (before) and after (1 and 3
months). The dependent variable was average FGF. The ANOVA of average FGF was significant between
groups: baseline, month 1, and month 3, (F=4.387, p=.013).
Post Hoc analysis using Tukey’s testing revealed statistical significance between FGF baseline
and month 3, but no statistical difference in procedure length or minutes to airway. Average FGF
between data set 1 (baseline=4.19 L/min) and date set 2 (month 1=3.94 L/min) decreased but did not
differ significantly. Average FGF from data set 2 (month 1=3.94 L/min) and data set 3 (month 3=3.53
L/min) again decreased but did not differ significantly. However, average FGF from data set 1
(baseline=4.16 L/min) and data set 3 (month 3=3.53 L/min) showed a statistically significant decrease
with (p=.011). For Tukey’s test summary see Table 6.
Discussion
Summary
Providing an educational intervention to anesthesia providers at this large university hospital
resulted in a significant increase in providers’ knowledge and attitudes toward sustainable use of
sevoflurane. Education was provided at an anesthesia weekly grand rounds meeting targeting the
largest number of providers in the department at once with a live presentation. Academic detailing
allowed providers who weren’t present to receive the educational information either in-person or via
email. Academic detailing, when educated and trained professionals familiar with the EBP information
take part in concerted efforts to educate staff for purposes of eliciting practice changes based on
current evidence was essential (Avorn, 2017). The efforts to reduce average FGF were reinforced
through extensive academic detailing consisting of regular and repeated personal interactions with
multiple staff as the project leader actively moved through and had contact with multiple staff members
in a given workday. A journal article was disseminated supporting the efforts to reduce waste of
sevoflurane and encourage use of lower FGF for both induction and maintenance of anesthesia. In
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addition, institutional support gained momentum throughout the project as the pharmacy department
enlisted the project to go system-wide and include recommending lower FGF in practice for not just
pediatric same-day-surgery cases, but all cases utilizing inhalational agents. In addition, the hospital
system adopted a green initiative, Mission Green, during the project to address system wide efforts to
reduce the carbon footprint as an institution. Reinforcement of the project efforts was discussed with
and supported by departmental leaders such as the director of perioperative services for the upcoming
children’s hospital, the chiefs of anesthesia residency, and the lead CRNA’s. An educational presentation
on sustainable use of anesthetic agents was delivered to the department very near the six-month mark
from the project’s initial effort. The continued academic detailing and education to department staff
echoes recommendations from previous researchers who found repeated, reinforcement is likely
needed to accomplish a lasting change in practice. (Gupta & Datta, 2020; Kennedy et al., 2019;
Lethbridge et al., 2007; Ryu et al., 2011; A. Singh et al., 2019; P. Singh et al., 2014; Tyagi et al., 2014).
The survey taken by respondents showed a favorable shift in knowledge and attitudes towards
more conscientious use of sevoflurane. Efforts to reinforce the projects goals were occurring several
times per week in personal interactions with staff, residents, and students. Widely shared with
department members were the Mission Green efforts of the hospital which were aligned with the efforts
of this project, as well as the interest from pharmacy in propagating the project into a system-wide
inititative to reduce FGF for any cases in which they are used. Staff were educated on the project’s aim
to make a practice change that is permanent and not only noticable during a brief data collection period.
Staff were encouraged to share their knowledge with any learners and students they worked with while
providing anesthesia. Provider feed back during the project was favorable and many reported it was
difficult to change their typical habits in practice. Positive reinforcement and encouragement was given
to anesthesia providers during academic detailing efforts.

25
Between data sets of baseline, month 1 and month 3 post-educational intervention, procedure
length did not differ significantly. The maximum procedure length was 180 minutes in attempt to
capture all same-day-surgery pediatric cases. Less than half-a-dozen cases were excluded based on
procedure length. If procedure length had differed significantly among data sets, additional calculations
would have been required. This is because the induction period, typically around five to ten minutes, is a
time where FGF are typically significantly higher than during tha maintenance phase of anesthesia. If a
group of cases had a lower procedure length, the induction phase would have a greater impact on
average FGF for any given case. For example, 7 minutes of FGF at induction will create a higher average
FGF in a 20 minute case versus a 60 minute case.
The reductions in average FGF recommended in this project did not result in an increase in time
to secure airway and are therefore considered a safe, efficient means of increasing sustainability
through reduced costs and decreased environmental pollution (A. Singh et al., 2019). The educational
intervention provided to anesthesia staff at this institution recommending using reduced FGF for the
delivery of sevoflurane for induction and maintenance of anesthesia mirrored the same efficiency found
in earlier interventions and did not result in any increase in minutes taken to secure the airway. In fact,
minutes to airway securement actually decreased in each consecutive data set although not at a
statistically significant amount. This may be attributable to the recommendation to prime the anesthesia
circuit prior to placing it on the patient’s face. The education provided to staff highlighted that placing
an unprimed circuit and mask on a patient’s face for inhalational induction is essentially synonymous to
restraining the child by the face with very little sevoflurane in the circuit for the first 30-60 seconds.
Waiting for the passage of three time constants, allows for a more rapid induction. The passage of three
time constants, typically less than a minute when priming an anesthesia circuit, allows 95% of that
circuit to be filled with the desired dose of sevoflurane for induction. In addition, after priming of a
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circuit, fresh gas flows can be reduced to a patient’s minute volume, simultaneously conferring the
efficiency of a primed circuit with a sustainably favorable FGF rate.
Interpretation
Previous studies have noted that decreases in average FGF as a reflection of inhalational agent
use, are a producible response to interventions with staff such as policy changes, anesthesia machine
soft defaults to 6 L/min FGF, staff education, and reminders to staff (Gupta & Datta, 2020; Kennedy et
al., 2019; Lethbridge et al., 2007; Ryu et al., 2011; A. Singh et al., 2019; P. Singh et al., 2014; Tyagi et al.,
2014). The educational intervention at this institution resulted in significant changes in anesthesia
providers’ attitudes and knowledge towards the sustainable use of sevoflurane. Also, the educational
intervention at this institution resulted in a statistically significant decrease over time in average FGF in
pediatric same-day-surgery cases. The project goal of reducing average FGF was attained. The goal of
reduction of average fresh gas flows was set at a 20% reduction. The attained reduction in average FGF
was 14.9% which was the noted statistically significant decrease from baseline data set to data set
three, collected in the third month after the implementation of the education to the department. Staff
responded favorably to education and ongoing project efforts, while serendipitous institutional support
arose and most likely helped the project gain ground and afforded additional support.
Limitations
The delivery of the pre-posttest immediately after the educational intervention creates a threat
to internal validity. The questions were answered for both “before” and “after” after receiving the
information regarding EBP sevoflurane use. Participant’s answers in the survey taken after receiving
education about sevoflurane may have been influenced by sensitization. Sensitization can influence
respondents’ answers particularly when attitudes are being measured (Polit & Beck, 2017).
Because this project focused on pediatric same-day-surgery cases which used an inhalational
induction method for anesthesia versus an intravenous induction method used in adults, results
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produced in this study may not be the same as those seen if cases of adult same-day-surgery cases were
studied. This project focused on anesthesia providers at a large university hospital. In such an
environment, many anesthesia providers are in training, and this could affect their ability to implement
practice change either in favor of making a practice change because they are at a stage of their training
where they are developing new skills, or against a change in practice that uses lower FGF. This is
because using higher flows assists in mask ventilation technique, like that used during mask inhalational
induction of a child and can compensate for an inadequate mask seal. In addition, a learner new to
pediatric anesthesia may not prioritize reducing flows over mastering basic airway management skills
needed in pediatric anesthesia. It is also possible that providers with many years of experience may find
it more difficult than newer learners to make changes in their practice if using higher than necessary FGF
has become dogmatic behavior. Retrieval of data from the EHR required some cases to be excluded due
to missing data from intranet downtimes or connectivity issues. Whether or not these relatively few
cases could have influenced average FGF rates, procedure times, and time to airway remains impossible
to determine. Data could only be tallied and analyzed from EHR’s which had complete anesthesia
records.
This project was carried out through the efforts of a staff CRNA completing a doctoral level
program. This was the first incidence in this department of a CRNA undertaking a large educational
centered EBP change and coincided with project rollouts from an inaugural class of student registered
nurse anesthetists’ projects. It was in an environment where multiple anesthesiology residents were
also completing projects, and could have failed to gain stronger support because of the novelty of a
CRNA attempting a department-wide change and because the project and its efforts may have been lost
among multiple other projects occurring at the time. The simultaneous occurrence of the institution’s
Mission Green and attention from the pharmacy department regarding cost saving measures was
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serendipitous and most likely prevented this project from being yet another in the long cast of student
projects being rolled out during this time.
Conclusions
Delivery of an education intervention to anesthesia providers can impact their practice to
produce a positive change. Specifically, recommendation for utilizing lower fresh gas flows by educating
staff on the impact of waste anesthesia gas production on costs, the environment, and patients. Based
on current expenditures, estimated savings of on sevoflurane annually based on percentage reduction
of FGF during this project could exceed $40,000. Suggestions of various minor practice changes that
could be implemented were delivered at the educational intervention. This information was reinforced
through a departmental journal article shared via intranet and through extensive academic detailing by
the researcher who was clinically active and available to interact with staff to propagate the
information, inform and discuss ongoing efforts.
This project sparked interest in the pharmacy department and generated additional efforts to
produce system-wide efforts to reduce waste anesthesia gas production in the interest of
pharmacoeconomic accountability and sustainability. Although the project proposal and garnering of
institutional support focused on economic benefits, education with staff focused on economic and
environmental concerns, as well as benefits to patients. It was believed that the idea of being monitored
by efforts of the institution for purposes of reducing costs alone, would be less palatable, and would
impact and motivate more anesthesia providers to change if it was not packaged solely as a “cost
reduction effort”. In addition, during the project’s evolution, an initiative was adopted by the hospital to
promote sustainability efforts throughout the institution. The interest of the pharmacy department in
this project and the adoption of a green initiative at the institution were used in discussions during
academic detailing to bolster support for the desired practice change. It encouraged providers to adopt
the use of lower FGF not as a temporary measure while data collection was underway, but as a
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permanent practice change that aligned with institutional efforts. The pharmacy department at the
institution is currently discussing strategies for monitoring of anesthesia gas usage in the future. In
effect, the efforts of the pharmacy, the institution’s green initiative and this project worked together to
further the project effort.
Volatile anesthetic agents are a predominant part of most anesthetics. In pediatric anesthesia,
sevoflurane is commonly used for induction and maintenance of anesthesia. With sevoflurane, a child is
anesthetized by an inhalational method, avoiding IV placement and needle sticks in a conscious child.
The delivery of sevoflurane has benefits due to its safe, rapid on and offset; however, there are
drawbacks. Some of these include unnecessary waste or excess use during delivery. This is because it is
administered via the flow of other fresh gases such as oxygen or air. These gases can be turned up in
excess of what is needed to deliver an adequate dose. This leads to increases in anesthesia expenses.
Other concerns include its contribution to environmental pollution, work exposure to volatile agents,
and airway irritation or cooling of patients with high FGF. Studies have identified interventions that
compel staff to make changes significantly reducing sevoflurane use (Lethbridge, et al., 2007). Despite
this, many of these studies did not have long-term follow up or have shown a rebound to baseline
tendencies months after the intervention occurs.
This project was evaluated over time, used academic detailing for reinforcement, and adopted
for onboarding of inexperienced providers. After the initial education was delivered and followed with
additional efforts to reinforce practice change, a significant decrease in average FGF occurred by month
3 post education. Providers have given feedback acknowledging it took them some length of time to
alter their practice to remember to use lower FGF and to turn the FGF down for the maintenance of
anesthesia. Although the decrease in average FGF didn’t reach the 20% goal set, continued
reinforcement and delivery of the evidence-based practice recommendations for sevoflurane should
continue to occur and to be reinforced. The first bi-annual repetition with an update of project progress
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was presented at department grand rounds again at 1 week short of 6 months from the initial
presentation. Recommended continued reinforcement and education had been cited by previous
investigators as a potential way to create a lasting practice change (Gupta & Datta, 2020; Kennedy et al.,
2019; Lethbridge et al., 2007; Ryu et al., 2011; A. Singh et al., 2019; P. Singh et al., 2014; Tyagi et al.,
2014). In this project, it appears continued efforts created a continued decline in average FGF, and these
efforts are continuing in the department.
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Table 1
Sevoflurane EBP Administration
Author/date
Gupta &
Datta, 2020

Purpose &
Variables
Comparison to
determine
best method
for induction
with the least
Sevoflurane
waste; Three
methods of
inhalational
induction;
Variables
were time to
intubation &
sevoflurane
consumption;
Also time to
loss of eyelash
reflex, IV
placement,
LMA insertion;
Incidence of
airway
complication,
tachycardia,
movement,
use of rescue
dose of
propofol.

Design/Method

Sample/Setting

Data Analysis

Findings

Appraisal

Parallel
Randomized
Controlled
Trial; After
informed
consent
obtained, each
child randomly
assigned to a
group
(standard
induction,
minute volume
induction, or
0.5-minute
volume
induction).
Subjects
excluded for
recent URI,
Airway
anomalies,
significant
pulmonary,
cardiac,
neurologic,
obesity, or
genetic
disorders.

45 Children
weighing
between 10 kg
& 20 kg
undergoing
same day
surgery in a
hospital in
India

SPSS software
used;
KruskallWallis test
used to
compare time
to intubation
& sevo
consumption;
MannWhitney used
to analyze
significant
differences in
KruskallWallis test; P
value .017
was found to
be significant;
ANOVA
compared
heart rates;
Complications
evaluated
using X2 and
Fisher exact
test

For pediatric
cases using
sevoflurane
for induction,
FGF at half
minute
volume
provided
similar
anesthetic
conditions
for LMA
insertion
with
minimum
sevoflurane
consumption

In pediatric
same day
surgery
patients, using
FGF of half the
patient’s
minute volume
for induction is
adequate for
pediatric same
day surgery
cases and
provide the
least amount of
sevoflurane
waste
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Author/date
Kennedy et
al., 2019

Lethbridge
et al., 2007

Purpose &
Variables
Determination
of the impact
of FGF used
during
induction of
overall FGF &
sevoflurane
consumption
during the
case;
Determine the
impact of an
intervention
for staff on
decreasing
FGF to lower
sevo waste;
Variables are
FGF rates
during
induction, FGF
rates for
cases,
consumption
of sevoflurane

Design/Method

Sample/Setting

Data Analysis

Findings

Appraisal

Quasiexperimental
before and
after; Data
collected over
11 months,
three before
and two
months
immediately
after
departmental
reinforcement
(emails, phone
calls) to reduce
FGF use, and
the next six
months
following the
two-month
date collection
period

Four operating
rooms in a
hospital in
New Zealand;
3199 cases had
data on FGF
anonymously
collected from
anesthesia
machine data

FGF rates
used during
induction
significantly
impact over
FGF rates and
sevoflurane
consumption;
Staff
intervention
can make an
impact on
FGF
rates/sevo
use but it
may rebound
after the
intervention

FGF rates at
induction affect
overall FGF
rates
significantly and
an intervention
with staff can
lower FGF rates
and sevo use,
but
reinforcement
may be needed
as the changes
may not be
lasting

Prospective
observational
study;
Variables are
total
anesthesia
time, sevo
amount used

Anesthesia
vaporizers in all
anesthetizing
locations in a
children’s
hospital for a
four-week
period to
determine sevo
use; Two
weeks into this,
an intervention
on decreasing
sevo use was
given to staff

All
anesthetizing
locations in a
children’s
hospital in
Australia; 764
cases analyzed

Used
GraphPad
Prism 7 for
analysis;
Timeweighted
mean used
for overall
FGF; KruskallWallis test
used for
comparison
across groups
with Dunn’s
multiple
comparison
test to
compare the
baseline
period with
both postintervention
periods;
Linear
regression
used to show
relationship
between FGF
and sevo use
Wilcoxon
Rank-Sum
Test used to
analyze &
compare
differences
between
groups

Induction
rooms used
60% of
sevoflurane,
but only
involved 15%
of total
anesthesia
time. Postintervention
sevo use
decreased by
53% overall
with an 87%
decrease in
use in
operating
rooms and
31%

Significant
reductions in
sevo use can be
obtained
through a staff
reminder
intervention
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Author/date

Purpose &
Variables

Design/Method

Sample/Setting

Data Analysis

Findings

Appraisal

decrease in
induction
rooms
Ryu et al.,
2011

Determining
the impact of
a policy
change aimed
at decreasing
sevoflurane
use and
decreasing
costs;
Variables are
number &
duration of
anesthesia
cases using
sevo; Number
of sevoflurane
bottles used

Observational
before and
after study;
Amount of
sevoflurane
used was
quantitated
before and
after a policy
change, five
weeks before,
and for the
next three fiveweek periods

Twelve
operating
rooms of a
hospital in
Seoul, South
Korea; 1700
cases reviewed
over 20-week
period; Five
weeks before
the policy
change (FGF
equal or less
than 1 L/min
for anesthesia
maintenance)
and fifteen
weeks after

Direct
comparison
was
performed
with the
extracted
data

Sevoflurane
use
decreased by
almost 40%
after a policy
change was
implemented
for staff to
maintain FGF
at equal to or
less than 1
L/min during
anesthesia
maintenance;
Effects seem
to diminish
over time

Implementing a
policy for
maintaining
sevoflurane FGF
rates at 1 L/min
or less can have
a significant
impact on sevo
consumption in
an anesthesia
department,
but that change
may fade over
time

A. Singh et
al., 2019

Determine if
low FGF
during
inhalational
induction with
sevo can
significantly
reduce sevo
consumption
without
adversely
affecting
induction
conditions;
Variables are
amount of
sevo used,
time to loss of
eyelash reflex,
adequate
anesthesia, IV
placement,
and airway
insertion.
Heart rate,
end-tidal

Randomized
Controlled
Trial; After
informed
consent
obtained,
children
between 1 and
5 yrs. old
undergoing
ophthalmic
procedures
randomized
into one of two
groups
(standard
induction and
low-flow
induction);
Time to
adequate
anesthesia
depth, IV
placement and
air placement
was recorded

Fifty children
undergoing
ophthalmic
procedures at
a hospital in
New Delhi,
India; Subjects
excluded for
cardiac,
neurological,
pulmonary,
genetic
disorders or
anticipated
difficult
airway, IV
access, or for
known allergy
to anesthetics
used

Data were
analyzed
using SPSS
software.
Quantitative
data were
compared
using
unpaired ttest.
Qualitative
variables
were
compared
using chisquared test.
P value of less
than 0.05 was
considered
significant.

Anesthesia
induction
using low
FGF
significantly
reduces sevo
consumption
without
affecting the
quality of
induction or
increasing
induction
time.

The quality and
efficiency of
induction with
sevoflurane in
children isn’t
compromised
using a low FGF
induction
technique
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Author/date

Purpose &
Variables
sevoflurane,
and total sevo
consumption.

Design/Method

Sample/Setting

Data Analysis

Findings

Appraisal

P. Singh et
al., 2014

Purpose was
to compare
two
techniques of
sevo
inhalational
induction in
children for
quality and
cost. Variables
are sevo
consumption,
FGF, time to
loss of
consciousness,
IV placement,
and airway
insertion.

Randomized
controlled trial;
After informed
consent
obtained,
children age 18 yrs. were
randomized to
one of two
groups: Group
1=Fixed 8%
induction until
+LOC vs. Group
2=Incrementalincrease sevo
every three
breaths
starting at 1%
group. Times to
+LOC, IV
placement, and
airway securing
were recorded
as was sevo
usage

One hundred
children
between 1-8
yrs. without
significant
health
conditions,
having surgery
at a hospital in
India; Subjects
were having
sevoflurane
induction of
anesthesia

Sevo
consumption
calculated
using the
Dion formula.
Data analyzed
with SPSS
software.
Statistical
significance
was set at
95%.
Normality of
data verified
using
KolmogorovSmirnov test
and variances
compared
with Leverne
test for
equality of
variance

An
incremental
method of
sevoflurane
induction in
children can
produce
decreases in
sevo usage
and cost
savings. Both
incremental
and fixed
sevo %
inductions
produce
comparable
safe and
efficient
inductions.

In pediatric
inductions, an
incremental
method of
induction is as
safe and
effective as a
fixed 8%
induction and is
more cost and
environmentally
conscientious.

Tyagi et al.,
2014

This study
aims to
evaluate and
compare total
coast of
sevoflurane
and propofol
for 1 hour of
anesthesia
utilizing three
anesthesia
techniques.

Randomized
controlled trial;
After informed
consent was
obtained, ASA
I-II adult
patients
undergoing
short duration
elective
surgeries were
randomized to

After informed
consent
obtained fortyfive ASA I-II
adult patients
were
randomized to
one of three
groups; Study
took place in a
hospital in
Delhi, India.

One-way
ANOVA
followed by
Tukey’s test
or Dunnett’s
T3 used for
comparison
of
quantitative
data among
the groups.
Nominal data

Sevoflurane
only
anesthetics
are superior
to propofol
and
sevoflurane
at two
different low
FGF
techniques.

Lower flow
techniques
shown to use
less
sevoflurane.
Sevoflurane
maintenance
with a propofol
induction is
more cost
effective with a
low flow

as were
complicating
events (reflex
tachycardia
heartrate
changes,
rescue
propofol)
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Author/date

Purpose &
Variables
Variables are
FGF, +/propofol,
sevoflurane
use,

Design/Method

Sample/Setting

Data Analysis

one of three
groups. Group
1-propofol
induction with
low flow
sevoflurane;
Group 2Propofol
induction with
lower flow
sevoflurane;
Group 3-Vital
capacity
sevoflurane
induction and
low flow
sevoflurane
maintenance.

Sevo
vaporizers
were weighed
to calculate
amount used
per case.

analyzed
using chisquared test.
Level of
significance
less than
0.05.

Findings

Appraisal
technique
during
maintenance.
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Table 2
Descriptive Statistics Procedure Length, Average Fresh Gas Flow, and Minutes to Airway
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Table 3
Survey Demographic Data: Provider Type & Years of Practice

Note. Question 1 “Q1” was the consent to take survey with “Q2” and “Q3” being provider type and years of experience
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Table 4
Before and After Survey Response Statistical Comparison
Paired Samples Test
Paired Differences

Significance

95% Confidence Interval

Mean
Pair

My knowledge of

1

Sevoflurane's

-1.723

Std.

Std. Error

Deviation

Mean

.910

.113

of the Difference
Lower
-1.949

Upper
-1.498

t

df
-

One-

Two-

Sided p

Sided p

64

<.001

<.001

64

<.001

<.001

15.263

contribution to
environmental
pollution - Before
presentation - My
knowledge of
Sevoflurane's
contribution to
environmental
pollution - After
presentation
Pair

My knowledge of

2

how much fresh gas
flows impact
Sevoflurane waste Before presentation
- My knowledge of
how much fresh gas
flows impact
Sevoflurane waste After presentation

-1.415

1.074

.133

-1.681

-1.149

10.628
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Paired Differences

Mean
Pair

My willingness to

3

integrate evidence

Significance

Std.

Std. Error

95% Confidence Interval

Deviation

Mean

of the Difference

t

df

One-

Two-

Sided p

Sided p

-1.095

1.103

.139

-1.373

-.817

-7.881

62

<.001

<.001

-1.406

1.137

.142

-1.690

-1.122

-9.895

63

<.001

<.001

-1.234

1.065

.133

-1.500

-.968

-9.270

63

<.001

<.001

into practice Before presentation
- My willingness to
integrate evidence
into practice - After
presentation
Pair

My willingness to

4

change my practice
to reduce
Sevoflurane waste
and environmental
pollution - Before
presentation - My
willingness to
change my practice
to reduce
Sevoflurane waste
and environmental
pollution - After
presentation

Pair

My willingness to

5

change my practice
when using
Sevoflurane to
reduce healthcare
costs - Before
presentation - My
willingness to
change my practice
when using
Sevoflurane to
reduce healthcare
costs - After
presentation
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Table 5.
ANOVA Summary Procedure Length, Average Fresh Gas Flow, and Minutes to Airway
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Table 6
Tukey’s Test Summary for FGF
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Figure 1.
Projected Project Timeline
Project Phase / Month

Project Plan &
Development
Literature Review &
Evidence Synthesis;
Proposal Draft
Departmental &
Stakeholder
Support;
Proposal submission to
Nursing Research
Council and IRB for
approval
Pre-intervention Data
Collection/Intervention
Baseline & EBP Survey
Data Collection
Month 1 postintervention Data
collection
Update Literature
Review
Month 3 postintervention Data
collection
Data Evaluation,
Analysis, and project
write up
Project Presentation
and submision

Jul
2020

AugSep

SepOct

OctNov

NovDec

JanMar
2021

Apr

Apr

May

May

May

Jun

46
Figure 2
Adjusted Project Timeline
Project Phase / Month

Project Plan &
Development
Literature Review &
Evidence Synthesis;
Proposal Draft
Departmental &
Stakeholder
Support;
Proposal submission to
Nursing Research
Council and IRB for
approval
Pre-intervention Data
Collection/Intervention
Baseline & EBP Survey
Data Collection
Month 1 postintervention Data
collection
Update Literature
Review
Month 3 postintervention Data
collection
Data Evaluation,
Analysis, and project
write up
Project Presentation
and submission

Jul
2020

AugSep

SepOct

OctNov

NovDec

JanMar
2021

Apr

MayJun

JulAug

Sept

Oct

NovDec

47
Figure 3
Summary of Survey Responses

48
Figure 4
Summary of Responses
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Figure 5
Summary of Responses
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Figure 6
Summary of Responses
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Figure 7
Summary of Responses
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Figure 8
Graphic of Minutes to Airway
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Figure 9
Graphic of Average Fresh Gas Flows
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Figure 10
Graphic of Procedure Length
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Appendix A
Educational Program and Pre/Post Educational Survey

HAT CAN

ED

ELL ME ER
IRB 20121

100

Environmental

ocial

Economic

56

Anesthesia gases are not always considered
Anesthe c contribu ons are arguably small over
all
Climate goals include 45% reduc on in carbon
emissions by 2030

aste anesthesia gases are emi ed unregulated
39% hospital emissions were from anesthesia
waste gases

evo urane 0% of the market
worldwide
H spends 300,000 yr on sevo

Pharmacy looking at inhala onal
agents
Pediatrics

57

Integrate
Evidence

Lower

FGF

hat led to to lower usage
Comparison of techniques
Before & A er

Maintenance

Induc on

58

ennedy et al.
2019

ta educa on &
reminders

26%

Lethbridge, Bouckley, &
Chambers, 200

ta ed. emails
phone calls

53%

Ryu et al, 2011

Policy change (1L min)

3 %

Tyagi et al, 2014

Adults C induc on
.5L min maintenancevs. prop
induc on

Low ows usedleast gas and
cost least wsevo only

Da a & Gupta, 2020

Prime circuit then 0.5xM , 1
xM , or standard 6L

afe and e ec ve as standard,
less waste & cost

Prime circuit Dropped ows
FM applica on

Equivalent condi ons Less
AG s

ingh et al, 2019
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Bene ts:
Conserves heat and moisture
Lower ows reduce the amount of
waste anesthesia gases

Lower ows increase anesthesia
providers pharmacoeconomic
accountability

Compound A
There were concerns of renal toxicity as sevo
reacts with agents in the C 2 absorbent
Rate studies show produc on of compound A
that lead to tubular necrosis in rats
However it was found that human and renal
biochemistry di ered signi cantly
e has an FDA recommenda on of 2 L min,
then 1 L min in 199

verhea ng
Caused by a reac on between desiccated
potassium containing C 2 absorbent and
vola le agent
C 2 absorbent was modi ed
If you are concerned you absorbent is
desiccated change it

60

ou can safely use lower fresh gas ow for
induc on
Flows can be lowered when you reach 1.0 MAC
or a er circuit prime (3 me constants)
6L min 6 L min prime, then turn down with
mask placement r induc ons with 0.5 M

Maintenance of anesthesia with sevo urane can
be done with 1 L min FGF
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Survey-adapted for Qualtrics:
Provider Type (select one):

Attending

Resident

CRNA

SRNA

Years of Practice: ______yrs.
Select the number for answers to questions for both before and after the presentation.
1=none, 2=a little, 3=some(what), 4=moderate, and 5=a lot/very much
1) My knowledge of sevoflurane’s contribution to environmental pollution
Before
1

2

3

4

5

2

3

4

5

After
1

2) My knowledge of how much FGF’s impact sevoflurane waste
Before
1

2

3

4

5

2

3

4

5

After
1

3) My willingness to integrate evidence into practice
Before
1

2

3

4

5

2

3

4

5

After
1

4) My willingness to change my practice to reduce sevoflurane waste and environmental pollution
Before
1

2

3

4

5

2

3

4

5

After
1

5) My willingness to change my practice when using sevoflurane to reduce healthcare costs
Before
1

2

3

4

5

2

3

4

5

After
1
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Appendix B
Data Collection Tool
Pt #

Pt age

Case
Length
(min)

Time=
Sevo
start

Time=
Airway
secured

Time=
Procedu
re finish

Min to
airway
secure

Total
min
Sevo
use

Average
FGF

Sevo ml
used
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Appendix C
Project Support
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Appendix D
WVUH and WVU IRB Approvals/Endorsement as NHSR
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Appendix E
Evaluation Plan

